Abstract
Although use of inhaled bronchodilators in infants with acute bronchiolitis is not supported by evidence-based guidelines, it is often justified by the belief in a subgroup effect in individuals developing atopic disease. We aimed to assess if inhaled epinephrine during acute bronchiolitis in infancy would benefit patients with later recurrent bronchial obstruction, atopic eczema, or allergic sensitisation. In the randomised, double-blind, multicentre Bronchiolitis ALL trial, 404 infants with moderate-to-severe acute bronchiolitis were recruited from eight hospitals in Norway to receive either inhaled epinephrine or saline up to every second hour throughout the hospital stay. Randomisation was done centrally, and the two study medications (20 mg/mL racemic epinephrine or 0.9% saline) were prepared in identical bottles. The dose given depended on the infant's weight: 0.10 mL, less than 5 kg; 0.15 mL, 5-6.9 kg; 0.2 mL, 7-9.9 kg; and 0.25 mL, 10 kg or more; all dissolved in 2 mL of 0.9% saline before nebulisation. The primary outcome was the length of hospital stay. In this follow-up study, 294 children were reinvestigated at 2 years of age with an interview, a clinical examination, and a skin prick test for 17 allergens, determin...Continue Reading
References
Nov 1, 1973·Postgraduate Medical Journal·S D Court
May 7, 2002·The Journal of Infectious Diseases·Ralph A TrippLarry J Anderson
Aug 29, 2006·Lancet·M Innes AsherUNKNOWN ISAAC Phase Three Study Group
Jul 7, 2007·Thorax·C S DevulapalliK-H Carlsen
Aug 19, 2007·American Journal of Respiratory and Critical Care Medicine·Sejal SaglaniPeter K Jeffery
Sep 27, 2007·Archives of Disease in Childhood. Education and Practice Edition·J Harry Baumer
Nov 23, 2007·The New England Journal of Medicine·Rui WangJeffrey M Drazen
Jan 27, 2010·Pediatrics·Joseph J Zorc, Caroline Breese Hall
Aug 6, 2011·The Pediatric Infectious Disease Journal·Lauren J StockmanGayle Fischer-Langley
Mar 13, 2012·Medical Microbiology and Immunology·Carolina ScagnolariGuido Antonelli
May 9, 2012·Nature Medicine·Patrick G Holt, Peter D Sly
Aug 18, 2012·Lancet Neurology·Maria Pia Sormani, Paolo Bruzzi
May 10, 2013·The New England Journal of Medicine·Maarten O BlankenUNKNOWN Dutch RSV Neonatal Network
Jun 14, 2013·The New England Journal of Medicine·Håvard Ove SkjervenKarin C Lødrup Carlsen
Sep 14, 2013·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Katarina BerankovaPetr Pohunek
Feb 19, 2014·Pediatrics·Vineeta MittalJeffrey Kahn
Apr 18, 2014·Current Opinion in Pediatrics·Alan R Schroeder, Jonathan M Mansbach
Oct 11, 2014·The Journal of Pathology·Raymond J Pickles, John P DeVincenzo
Oct 29, 2014·Pediatrics·Shawn L RalstonSinsi Hernandez-Cancio
Nov 27, 2014·The Journal of Infectious Diseases·Kohei HasegawaCarlos A Camargo
Citations
Sep 1, 2015·The Lancet. Respiratory Medicine·Joseph J Zorc
Feb 24, 2016·Expert Review of Respiratory Medicine·Silvia VandiniMarcello Lanari
Mar 15, 2016·The British Journal of Dermatology·T L BerentsP Gjersvik
Feb 13, 2018·International Journal of Cosmetic Science·T TohgasakiH Fukuda
Feb 15, 2018·Journal of the European Academy of Dermatology and Venereology : JEADV·Z AliS F Thomsen
Nov 30, 2018·Expert Review of Respiratory Medicine·Matti Korppi
Jan 8, 2019·Acta Paediatrica·Matti KorppiPaula Heikkilä
Sep 28, 2017·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Rosemary MegalaaGustavo Nino
Aug 31, 2019·PloS One·Leif Bjarte RolfsjordKarin C Lødrup Carlsen
Mar 24, 2020·ERJ Open Research·Jon Olav Gjengstø HunderiHåvard Ove Skjerven
May 26, 2017·Acta Paediatrica·Varpu EleniusTuomas Jartti
Jun 9, 2017·BMC Pediatrics·Teresa Løvold BerentsPetter Gjersvik
Jun 25, 2016·Thorax·Orianne DumasCarlos A Camargo
Jul 13, 2021·The Open Respiratory Medicine Journal·Amar Al ShibliHassib Narchi